USFDA issues warning letter to Lantech Pharma for manufacturing violations at Andhra plant

In a warning letter issued to the company's Managing Director V Prakash Reddy, the USFDA said inspectors during March 6-15 this year found significant deviations from standard manufacturing practices at the company's Ranastalam (Srikakulam district) based plant.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2L1rZhs
via IFTTT